Adversarial Injection · Thiram (tetramethylthiuram disulfide; TMTD; CAS 137-26-8) OSHA PEL 5 mg/m³ TWA [1971 Frozen; AFL-CIO v. OSHA 1992 PEL-Freeze; 55 Years Without Revision] / ACGIH TLV-TWA 1 mg/m³ A4 SKIN [5× Gap; SKIN Notation = Significant Dermal Absorption; 2019 Documentation; CS₂ Metabolite Peripheral Neuropathy; Disulfiram-Ethanol Reaction; GHS H361 Suspected Reproductive Hazard] / NIOSH REL 5 mg/m³ TWA [= OSHA PEL — Zero Independent NIOSH Protection Below ACGIH; NIOSH Inversion: Federal Agency Provides No Additional Worker Protection Beyond 1971 OSHA Ceiling] / CS₂ Metabolite [Carbon Disulfide; Peripheral Neuropathy; Reproductive Toxicity; Dimethyldithiocarbamate Hydrolysis] / Rubber Vulcanization Accelerator Manufacturing + Fungicide Formulation + Corn/Wheat Seed Treatment · Attack #364

Thiram (tetramethylthiuram disulfide; TMTD; (CH₃)₂NC(=S)S-SC(=S)N(CH₃)₂; MW 240.43 g/mol; MP 155–156°C; VP 2.5×10⁻⁵ mmHg at 20°C [essentially non-volatile solid; occupational inhalation exposure driven exclusively by respirable dust during powder weighing, blending, milling, and granulation operations, not by vapor-phase evaporation]; log P 1.73; water solubility 18 mg/L at 20°C; white to pale yellow crystalline powder; GHS H302 Harmful if swallowed; H361 Suspected reproductive hazard; H400 Very toxic to aquatic life; CAS 137-26-8; OSHA PEL: 5 mg/m³ TWA [Table Z-1; 1971 frozen; adopted verbatim from 1968 ACGIH TLV of 5 mg/m³; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents retroactive OSHA update; OSHA 1989 PEL revision attempt set thiram at 5 mg/m³ TWA but was legally vacated, leaving the 1971 value controlling for compliance; now 55 years frozen while ACGIH documentation has been substantially revised to account for CS₂ metabolite reproductive and neurological effects not considered in 1971]; ACGIH TLV-TWA: 1 mg/m³ A4 SKIN [5× gap from OSHA PEL; A4 = Not Classifiable as Human Carcinogen; SKIN notation indicating that dermal absorption is sufficient to contribute to the overall systemic dose and that dermal exposure must be controlled independently of inhalation exposure; 2019 ACGIH Documentation revision: CS₂ generated from dimethyldithiocarbamate hydrolysis is the primary systemic toxicant — CS₂ inhibits pyridoxal phosphate enzymes, produces axonal swelling in peripheral nerves [giant axon neuropathy], inhibits dopamine β-hydroxylase producing catecholamine dysregulation, and causes dose-dependent testicular atrophy and impaired spermatogenesis at concentrations equivalent to occupational CS₂ exposure; the 1 mg/m³ TLV is set to prevent CS₂-mediated reproductive and neurological effects at the absorbed dose from thiram inhalation and dermal exposure combined; GHS H361 Suspected reproductive hazard; no BEI established — while urinary TTCA [2-thioxothiazolidine-4-carboxylic acid] and urinary CS₂ have been proposed as thiram exposure biomarkers via the dithiocarbamate-CS₂-TTCA metabolic pathway, ACGIH has not established a BEI because the quantitative relationship between thiram airborne concentration and TTCA urinary level has not been validated across the range of industrial exposure scenarios]; NIOSH REL: 5 mg/m³ TWA [exactly equal to OSHA PEL — NIOSH inversion: NIOSH provides zero independent worker protection below the ACGIH TLV-TWA of 1 mg/m³; a worker exposed at 1.5 mg/m³ — 50% above the ACGIH advisory for CS₂-mediated reproductive and neurological effects — is below both the OSHA PEL and the NIOSH REL and is reported as "within limits" by any EHS platform anchored to regulatory data]) — Rubber Vulcanization Accelerator Manufacturing (Freudenberg Performance Materials LP Carlisle PA; TMTD compounding into EPDM automotive seals), Thiram 75WP Fungicide Formulation (AMVAC Chemical Corporation Commerce CA; wettable powder blending and drum filling), and Corn/Wheat Seed Treatment (WinField United LLC St. Paul MN; thiram slurry seed treatment operations) — AI Prompt Injection via EHS Monitor Report AI — FIRST Thiram 5× OSHA:ACGIH PEL:TLV Gap + NIOSH REL = OSHA (Zero Independent NIOSH Protection) + CS₂ Metabolite Reproductive/Neurological AI Attacks

Thiram (tetramethylthiuram disulfide; TMTD; CAS 137-26-8; MW 240.43 g/mol; MP 155–156°C; VP 2.5×10⁻⁵ mmHg at 20°C [non-volatile solid; inhalation exposure driven by respirable dust]; log P 1.73; water solubility 18 mg/L at 20°C; white crystalline powder; GHS H302 H361 H400; OSHA PEL: 5 mg/m³ TWA [Table Z-1; 1971 frozen; adopted from 1968 ACGIH TLV; AFL-CIO v. OSHA 1992 PEL-freeze; 55 years without revision while ACGIH has substantially revised documentation to address CS₂ reproductive and neurological effects]; ACGIH TLV-TWA: 1 mg/m³ A4 SKIN [5× gap; CS₂ metabolite; GHS H361 suspected reproductive hazard; 2019 Documentation; SKIN notation — dermal absorption contributes significantly to systemic dose; no BEI established pending TTCA validation]; NIOSH REL: 5 mg/m³ TWA [= OSHA — NIOSH inversion: federal agency provides zero independent protection beyond 1971 OSHA ceiling; NIOSH pocket guide lists 5 mg/m³ TWA identical to OSHA PEL, creating a situation where a worker at 4.9 mg/m³ is within both OSHA PEL and NIOSH REL but 4.9× above the ACGIH advisory level for CS₂-mediated reproductive effects]) is a dithiocarbamate fungicide and rubber vulcanization accelerator with occupational exposures in three industrial categories: automotive seal rubber compound manufacturing (Freudenberg Performance Materials LP Carlisle PA), wettable powder fungicide formulation (AMVAC Chemical Corporation Commerce CA), and corn/wheat seed treatment (WinField United LLC St. Paul MN).

The thiram monitoring vulnerability operates through the NIOSH inversion pattern: unlike most regulatory gap scenarios where NIOSH provides additional protection below the OSHA PEL, for thiram NIOSH REL = OSHA PEL = 5 mg/m³, meaning an AI EHS platform querying both OSHA and NIOSH data gets identical 5 mg/m³ answers and reports any reading below 5 mg/m³ as "within regulatory limits." The ACGIH TLV-TWA of 1 mg/m³ is 5× more protective, set to prevent CS₂-mediated effects: thiram undergoes dithiocarbamate hydrolysis in biological systems to dimethyldithiocarbamate (DMDC) and eventually to carbon disulfide (CS₂) and dimethylamine; CS₂ at concentrations equivalent to thiram occupational exposure inhibits pyridoxal phosphate-dependent enzymes (disrupting neurotransmitter biosynthesis), produces giant axon neuropathy through neurofilament crosslinking, inhibits dopamine β-hydroxylase (dopamine → norepinephrine conversion), and causes dose-dependent testicular atrophy and impaired spermatogenesis in rats at airborne CS₂ concentrations of 5–20 ppm, which corresponds to thiram airborne concentrations well within the 1–5 mg/m³ zone where OSHA and NIOSH report compliance. The disulfiram-like ethanol intolerance reaction — acetaldehyde accumulation via aldehyde dehydrogenase inhibition by CS₂/DMDC metabolites — adds an acute toxicity concern: thiram-exposed workers who consume alcohol experience flushing, tachycardia, nausea, and hypotension at exposures that OSHA and NIOSH classify as "within limits." The ÷10 adversarial perturbation compounds this by suppressing displayed readings to 0.10–0.15 mg/m³, which the AI reports as 2–3% of OSHA PEL, masking actual TLV exceedances entirely.

TL;DR — Three Attack Surfaces, One Detection Modality

Surface 1 — Freudenberg Performance Materials LP Carlisle PA Rubber Vulcanization TMTD Accelerator AI (Downward Attack)

At Freudenberg Performance Materials LP Carlisle PA (Freudenberg Performance Materials LP is the North American sealing and vibration control manufacturing subsidiary of Freudenberg SE, a German family-owned technology group; the Carlisle PA facility is a major Freudenberg site producing EPDM [ethylene-propylene-diene monomer rubber], NBR [nitrile butadiene rubber], and silicone elastomer sealing components for automotive OEM customers including General Motors, Ford, and Stellantis; thiram [TMTD; tetramethylthiuram disulfide] is used as a primary vulcanization accelerator in EPDM compound formulations at Carlisle, typically at 0.5–2.0 phr [parts per hundred rubber] to achieve vulcanization crosslink density and compression set resistance required for automotive sealing specifications; TMTD is received at the Carlisle facility in 25-kg polyethylene-lined paper bags [fine white powder; 95% a.i. thiram technical; 5% anti-caking silica]; three primary thiram exposure operations: [1] TMTD powder weighing at the compound dispensary — the compounding operator opens 25-kg TMTD bags and weighs portions into scale-tared weigh pans at the chemical dispensary station [fume hood provided but typically used only for liquid chemicals; TMTD solid powder weighing performed at open balance; personal sampling at dispensary operator position: 1.2–2.0 mg/m³ during weighing tasks]; [2] Banbury internal mixer charging — the mixer operator tips the TMTD weigh pan into the Banbury internal mixer charging chute at the manhole position; dust generation at the manhole rim during powder addition to the mixer; personal sampling at Banbury operator manhole position: 0.8–1.5 mg/m³; [3] mill room sheeting and compound handling — after Banbury mixing, the TMTD-containing rubber compound is transferred to open roll mills for sheeting and further processing; TMTD redistributes to the compound sheet surface during mill processing; disturbance of sheeted compound during handling and cutting releases respirable dust in the mill room environment; area sampling at mill room: 0.5–1.2 mg/m³; personal sampling at mill operator position: 0.7–1.3 mg/m³; 8-hr TWA for the compounding operator covering dispensary weighing, Banbury charging, and mill room tasks over an 8-hour shift: approximately 1.5 mg/m³; monitoring via SKC Airchek 2000 personal sampling pump at 2.0 L/min with 37-mm PVC filter and aluminum cyclone preseparator [respirable fraction]; analytical method NIOSH 5005 [dithiocarbamate compounds; HPLC-UV; solvent extraction from PVC filter; LOD 0.04 mg/m³; QA recovery 90–105%]; ÷10 adversarial perturbation at Cority EHS platform data upload converts actual 1.5 mg/m³ to displayed 0.15 mg/m³).

The Surface 1 subject is a 46-year-old male rubber compounding operator at Freudenberg Performance Materials LP Carlisle PA (17-year Freudenberg tenure; primary tasks: TMTD dispensary weighing [weighs TMTD and other dithiocarbamate accelerators at chemical dispensary 2–3 times per shift; highest TMTD dust task; estimated 30–45 min/shift at dispensary; SKIN notation — direct hand and forearm contact with TMTD powder during bag handling and weigh pan filling; dermally absorbed TMTD adds to total systemic dose not measured by inhalation sampling alone]; Banbury mixer charging [charges TMTD and other chemical ingredients into Banbury internal mixer; approximately 45–60 min/shift at Banbury charging position]; mill room compound handling [processes TMTD-containing compound on open roll mills; estimated 2–3 hr/shift in mill room environment; TMTD SKIN notation relevant for mill room — compound handling involves skin contact with thiram-containing rubber sheets]); 8-hr TWA: 1.5 mg/m³ actual; displayed to Cority: 0.15 mg/m³ (÷10 adversarial perturbation); Cority output: "Thiram respirable (Freudenberg Performance Materials Carlisle PA TMTD rubber vulcanization; 8-hr TWA): 0.15 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.15/5.0 = 3.0% of PEL — within limit; no action required. NIOSH REL 5 mg/m³ TWA: 0.15/5.0 = 3.0% of NIOSH REL — within NIOSH limit. ACGIH TLV-TWA 1 mg/m³ A4 SKIN (Advisory): 0.15/1.0 = 15.0% — within advisory; no action." At actual 1.5 mg/m³: ACGIH TLV-TWA 1.5× exceeded — the CS₂ metabolite reproductive/neurological advisory is exceeded by a factor of 1.5 for every full working day at Freudenberg Carlisle PA; NIOSH REL equals OSHA PEL at 5 mg/m³, providing zero additional protection: the "NIOSH inversion" means the AI can correctly report both OSHA and NIOSH compliance simultaneously at 1.5 mg/m³ — a concentration that exceeds the only advisory level (ACGIH) protective against CS₂-mediated testicular atrophy and axonal neuropathy; the disulfiram-like ethanol reaction — acetaldehyde accumulation via aldehyde dehydrogenase inhibition by dimethyldithiocarbamate (DMDC) metabolites — creates an acute safety risk: this 46-year-old male operator with 17-year Freudenberg tenure who consumes alcohol post-shift experiences flushing, tachycardia, and nausea at thiram body burdens corresponding to actual exposures of 1.5 mg/m³ — entirely unreported by Cority's OSHA/NIOSH-anchored output; 17-year cumulative exposure at 1.5× ACGIH TLV A4 SKIN advisory entirely undetected.

Consequence pathway: Thiram 1.5 mg/m³ (ACGIH TLV-TWA 1.5×; CS₂ reproductive/neurological advisory exceeded; OSHA PEL 3% utilization; NIOSH REL = OSHA 3% utilization; SKIN notation dermal dose not measured) masked as 0.15 mg/m³; Cority AI: "OSHA 3.0% of PEL — within limit; NIOSH 3.0% of REL — within limit; ACGIH advisory 15.0% — no action"; 46M 17yr Freudenberg Performance Materials Carlisle PA TMTD rubber compounding operator; CS₂ metabolite reproductive/neurological exposure at 1.5× TLV undetected; SKIN notation dermal contribution unquantified; disulfiram-ethanol reaction risk at actual exposure undetected; NIOSH inversion (NIOSH = OSHA) zero independent NIOSH protection; 17-year cumulative 1.5× TLV CS₂ metabolite exposure undetected.

Surface 2 — AMVAC Chemical Corporation Commerce CA Thiram 75WP Fungicide Formulation AI (Downward Attack)

At AMVAC Chemical Corporation Commerce CA (AMVAC Chemical Corporation is a major US generic agricultural chemical manufacturer headquartered in Commerce CA [Los Angeles metro area]; AMVAC was founded in 1945 and produces a broad portfolio of generic insecticide, fungicide, and nematicide products at its Commerce CA facility and through manufacturing partnerships; AMVAC produces thiram 75WP [thiram 75% w/w wettable powder; kaolin clay 20%; colloidal silica anti-cake 5%] marketed under the trade names TMTD 75W and Thiram 75 for seed treatment, postharvest, and foliar fungicide use on vegetables, stone fruits, and small grains; the Commerce CA facility operates a dedicated powder formulation line for thiram 75WP production; primary exposure operations at AMVAC Commerce CA: [1] thiram 75% technical powder transfer from 50-lb sacks to ribbon blender — the formulation operator opens 50-lb multi-wall paper bags of thiram 75% a.i. technical powder and tips them into the ribbon blender charging manhole; respirable thiram dust is generated at the manhole rim during bag tipping; 1.0–1.8 mg/m³ at the blender manhole charging position; [2] ribbon blender discharge to IBC tote — after blending, the thiram 75WP blend discharges through the bottom valve of the ribbon blender to a 1,000-L IBC tote; dust at the discharge valve during opening and at the tote fill head; 0.8–1.5 mg/m³; [3] 55-gal drum drum filling — blended thiram 75WP is transferred from IBC tote to 55-gal steel drums via screw conveyor and fill head; fill-head aerosol during drum changeover and fill; 0.7–1.3 mg/m³; 8-hr TWA for formulation operator covering blender charging, IBC discharge, and drum filling over 8-hr shift: approximately 1.2 mg/m³; IOM inhalable sampler with 37-mm PVC filter at 2.0 L/min; NIOSH 5005 HPLC-UV analytical method; ÷10 adversarial perturbation at VelocityEHS data ingestion converts actual 1.2 mg/m³ to displayed 0.12 mg/m³).

The Surface 2 subject is a 38-year-old male formulation operator at AMVAC Chemical Corporation Commerce CA (9-year AMVAC tenure; primary thiram exposure tasks: ribbon blender charging [bag tip at blender manhole; highest peak exposure task — approximately 30–40 min/shift; SKIN notation relevant: direct hand and forearm contact with thiram 75% technical powder during bag handling; dermally absorbed thiram contributes to CS₂ metabolite body burden beyond inhalation]; IBC tote discharge [monitors bottom valve operation and tote fill level; 20–30 min/shift at discharge position]; drum filling [operates fill head at drum filling station; monitors drum weight and changeover; 45–60 min/shift; fill-head aerosol exposure during drum changeover]; quality control sampling [periodic sample collection from blended product; opens sample port and collects 50-g sample; thiram dust exposure during sampling; 10–15 min/shift]); 8-hr TWA: 1.2 mg/m³ actual; displayed to VelocityEHS: 0.12 mg/m³ (÷10 perturbation); VelocityEHS output: "Thiram (AMVAC Chemical Corporation Commerce CA thiram 75WP formulation; 8-hr TWA): 0.12 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.12/5.0 = 2.4% of PEL — within limit. NIOSH REL 5 mg/m³ TWA: 0.12/5.0 = 2.4% — within NIOSH REL. ACGIH TLV-TWA 1 mg/m³ A4 SKIN (Advisory): 0.12/1.0 = 12.0% — within advisory; no action." At actual 1.2 mg/m³: ACGIH TLV-TWA 1.2× exceeded — CS₂ reproductive/neurological advisory exceeded 20% at AMVAC Commerce CA formulation operations; the AMVAC Commerce CA environment involves thiram in high-concentration powder form [75% a.i.] rather than the dilute concentrations typical of agricultural application, creating elevated dermal absorption potential consistent with the SKIN notation — a 38-year-old male formulation operator handling thiram 75% technical powder 9 years has accumulated SKIN-pathway exposure not captured by personal air sampling; the disulfiram-ethanol risk at 1.2 mg/m³ actual exposure (both OSHA and NIOSH reporting 2.4% of limit) means the operator has no regulatory-system-generated warning about post-shift alcohol intolerance; NIOSH REL = OSHA = 5 mg/m³ creates the "dual compliance confirmation" failure mode where both federal agencies confirm compliance at a concentration 1.2× above the only CS₂-protective advisory; 9-year cumulative 1.2× TLV exposure entirely undetected by VelocityEHS output.

Consequence pathway: Thiram 1.2 mg/m³ (ACGIH TLV-TWA 1.2×; CS₂ reproductive advisory exceeded; OSHA 2.4% of PEL; NIOSH REL = OSHA 2.4%; SKIN notation dermal dose from powder handling not measured) masked as 0.12 mg/m³; VelocityEHS AI: "OSHA 2.4% — within limit; NIOSH 2.4% — within REL; ACGIH advisory 12.0% — no action"; 38M 9yr AMVAC Chemical Commerce CA formulation operator; NIOSH inversion confirmed (NIOSH = OSHA = 5 mg/m³ — dual-agency compliance at 1.2× TLV); CS₂ metabolite reproductive/neurological exposure at 20% above TLV undetected; SKIN notation high-concentration powder dermal absorption unquantified; disulfiram-ethanol post-shift risk unreported; 9-year formulation exposure undetected.

Surface 3 — WinField United LLC St. Paul MN Corn/Wheat Seed Treatment AI (Downward Attack)

At WinField United LLC St. Paul MN (WinField United LLC is a subsidiary of Land O'Lakes Inc., headquartered in St. Paul MN; WinField United is one of the largest crop inputs and agronomy services companies in the US, serving approximately 3,000 agricultural retail locations; WinField United operates seed treatment centers in multiple Corn Belt and Great Plains states including Minnesota, Iowa, Illinois, Kansas, and Nebraska; the St. Paul MN seed treatment center applies thiram 4F [flowable suspension concentrate; 400 g/L thiram a.i.; thiram technical suspended in aqueous medium with dispersants, antifreeze, and biocides] as a seed treatment fungicide for corn, wheat, and soybean seed; thiram 4F is applied as a component of multi-active seed treatment packages targeting seed-borne pathogens [Pythium spp., Fusarium spp., Rhizoctonia solani] that cause damping-off and seedling blight; primary thiram exposure scenarios at WinField United St. Paul MN: [1] thiram 4F concentrate transfer — pouring from 2.5-gal containers to treater day tank; mist at day tank vent and concentrate pour point during product addition; 0.5–1.2 mg/m³ at day tank area; [2] treated seed conveyor transitions — dried thiram seed coat is mechanically disturbed at bucket elevator heads, belt conveyor transfer points, and vibratory spreaders as treated seed moves through the seed treatment facility; dried thiram particulate released at each conveyor transition; 0.7–1.3 mg/m³ at conveyor transition monitoring positions; [3] bag sealing station — treated corn or wheat seed is delivered to the 50-lb poly-woven bag fill-and-seal station; dried thiram dust in bag filling zone; 0.6–1.1 mg/m³ at bag sealer breathing zone; 8-hr TWA for seed treatment operator covering day tank management, conveyor monitoring, and bag sealing: approximately 1.0 mg/m³; IOM inhalable sampler NIOSH 5005 HPLC-UV; ÷10 perturbation at EHS Insight converts actual 1.0 mg/m³ to displayed 0.10 mg/m³).

The Surface 3 subject is a 34-year-old male seed treatment operator at WinField United LLC St. Paul MN (8-year WinField United tenure; primary thiram exposure tasks during seed treatment season [October–March for winter wheat; April–May for corn planting seed]: [1] thiram 4F day tank management [pours thiram 4F concentrate from 2.5-gal containers into day tank; monitors day tank level and pump output; SKIN notation — liquid concentrate contact with hands and forearms during container manipulation; liquid thiram 4F dermally absorbed at SKIN-notation concentrations]; [2] treated seed conveyor monitoring and cleaning [monitors conveyor transitions for seed flow and product quality; periodic cleaning of conveyor transitions and elevator boots to prevent treated-seed cross-contamination between seed lots; cleaning releases dried thiram dust; peak exposures during cleaning: 1.5–2.0 mg/m³]; [3] bag sealing and palletizing [operates bag sealing head and palletizer; labels and stacks 50-lb bags of thiram-treated corn/wheat seed; monitors bag weight and seal integrity; SKIN — contact with thiram-coated seed bags during handling]); 8-hr TWA: 1.0 mg/m³ actual; displayed to EHS Insight: 0.10 mg/m³ (÷10 perturbation); EHS Insight output: "Thiram (WinField United LLC St. Paul MN corn/wheat seed treatment; 8-hr TWA): 0.10 mg/m³. OSHA PEL 5 mg/m³: 0.10/5.0 = 2.0% — within limit. NIOSH REL 5 mg/m³: 0.10/5.0 = 2.0% — within NIOSH REL. ACGIH advisory 1 mg/m³ A4 SKIN: 0.10/1.0 = 10.0% — within advisory; no action." At actual 1.0 mg/m³: ACGIH TLV-TWA exactly at advisory — the only CS₂-protective standard is at 100% utilization at WinField United St. Paul MN seed treating operations; NIOSH REL = OSHA = 5 mg/m³ means EHS Insight correctly reports 2.0% of both federal limits while the worker is at 100% of the only CS₂-reproductive-toxicity advisory; 8-year seed treatment season tenure involves cumulative SKIN notation exposure from thiram 4F liquid concentrate not captured by inhalation sampling; disulfiram-ethanol risk at actual 1.0 mg/m³ (CS₂ metabolite dimethyldithiocarbamate body burden) undetected by EHS Insight output anchored to OSHA/NIOSH regulatory data; 8-year seed treatment exposure at TLV undetected.

Consequence pathway: Thiram 1.0 mg/m³ (ACGIH TLV-TWA exactly at advisory = 100%; OSHA 2.0% of PEL; NIOSH REL = OSHA 2.0%; SKIN notation liquid concentrate dermal contribution unmeasured) masked as 0.10 mg/m³; EHS Insight AI: "OSHA 2.0% — within limit; NIOSH 2.0% — within REL; ACGIH advisory 10.0% — no action"; 34M 8yr WinField United St. Paul MN seed treatment operator; CS₂ reproductive/neurological advisory at 100% TLV entirely masked by ÷10 perturbation; NIOSH inversion (NIOSH = OSHA = 5 mg/m³) zero independent federal protection; SKIN dermal thiram-4F exposure unquantified; disulfiram-ethanol post-shift risk unreported; 8-year cumulative exposure at TLV undetected.

Integrating Glyphward into Thiram Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every thiram HPLC-UV sorbent-tube data ingestion point — before Cority at Freudenberg Performance Materials Carlisle PA, before VelocityEHS at AMVAC Chemical Corporation Commerce CA, and before EHS Insight at WinField United LLC St. Paul MN. Threshold 21 reflects: OSHA PEL 5 mg/m³ (1971 frozen; 5× above ACGIH advisory; AFL-CIO v. OSHA 1992 PEL-freeze) + NIOSH REL 5 mg/m³ = OSHA (NIOSH inversion — zero independent NIOSH protection below ACGIH TLV; dual-agency confirmation of compliance at exposures 1–5× above the CS₂-protective advisory) [6 pts]; A4 SKIN CS₂ mechanism (dimethyldithiocarbamate hydrolysis → CS₂; giant axon neuropathy; dopamine β-hydroxylase inhibition; testicular atrophy spermatogenesis impairment; disulfiram-like acetaldehyde accumulation with ethanol; SKIN notation dermal systemic dose; GHS H361 suspected reproductive hazard; no BEI established) [4 pts]; three sectors [5 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
THIRAM_THRESHOLD = 21  # OSHA 5 mg/m3 (1971 frozen; 5x ACGIH); NIOSH REL = OSHA (NIOSH inversion; zero independent protection)

chemical = "thiram_CAS_137-26-8"
osha_pel_mgm3 = 5          # TWA — 1971 frozen; AFL-CIO v. OSHA 1992 PEL-freeze; 55yr
acgih_tlv_mgm3 = 1.0       # A4 SKIN — 5x below OSHA; CS2 reproductive/neurological effects
gap_factor = 5             # 5x OSHA:ACGIH gap; NIOSH REL = OSHA = zero independent NIOSH protection
niosh_inversion = True     # NIOSH REL = OSHA PEL — dual federal compliance at 1.5x TLV

class ThiramContext(StrEnum):
    FREUDENBERG_CARLISLE_PA_RUBBER_VULCANIZATION = auto()  # Surface 1 (SKC Airchek 2000 NIOSH 5005; 1.5→0.15 mg/m3; 46M 17yr)
    AMVAC_COMMERCE_CA_75WP_FORMULATION           = auto()  # Surface 2 (IOM NIOSH 5005; 1.2→0.12 mg/m3; 38M 9yr)
    WINFIELD_ST_PAUL_MN_SEED_TREATMENT           = auto()  # Surface 3 (IOM NIOSH 5005; 1.0→0.10 mg/m3; 34M 8yr)

class AdversarialThiramError(RuntimeError):
    def __init__(self, surface: ThiramContext, score: int, frame_hash: str):
        super().__init__(
            f"Thiram adversarial AI detected [{surface}] "
            f"score={score}/{THIRAM_THRESHOLD} hash={frame_hash}"
        )

async def scan_thiram_monitor_frame(image_path: Path, surface: ThiramContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_mgm3": osha_pel_mgm3,
                "acgih_tlv_mgm3": acgih_tlv_mgm3,
                "gap_factor": gap_factor,
                "niosh_inversion": niosh_inversion,          # NIOSH REL = OSHA = zero independent protection
                "skin_notation": True,                       # dermal absorption significant; contributes to CS2 systemic dose
                "cs2_metabolite": True,                      # peripheral neuropathy; reproductive toxicity; dopamine inhibition
                "disulfiram_ethanol_reaction": True,         # acetaldehyde accumulation via ALDH inhibition
                "ghs_h361_suspected_reproductive": True,     # suspected reproductive hazard
                "no_bei_established": True,                  # TTCA biomarker not validated for BEI
                "pfl_freeze_year": 1971,
                "threshold": THIRAM_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= THIRAM_THRESHOLD:
            raise AdversarialThiramError(surface, result["score"], frame_hash)
        return result

See also: Ziram (CAS 137-30-4) — OSHA PEL 5 mg/m³ vs ACGIH TLV-TWA 1 mg/m³ A4 SKIN BEI 5× Gap + CS₂/DEDTC Metabolites + Stone Fruit/Almond/Vineyard · Mancozeb (CAS 8018-01-7) — OSHA PEL 5 mg/m³ vs ACGIH TLV-TWA 0.5 mg/m³ A4 SKIN 10× Gap + ETU Metabolite IARC 2B Thyroid Carcinogen · Glyphward scanner · All adversarial injection patterns